Clinical Trial Update: Bevacizumab Beyond Progression (BBP) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on Bevacizumab Beyond Progression in malignant glioma including glioblastoma and gliosarcoma; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma
• Malignant Glioma

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Duke University | Conditions: Malignant Glioma, Grade 4 Malignant Glioma | Phase 2 | Status: COMPLETED | Results posted: 2020-12-02